Cholera

Cholera is an acute, diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae. The infection is often mild or without symptoms, but sometimes it can be severe.

Cholera Transmission, Spread, Prevention & Treatment

Cholera is an infection caused by the bacteria Vibrio cholerae. The bacteria is often transmitted via contaminated water or food.

Latest Cholera News and Research

Scientists reveal how cholera bacteria activate toxin genes in the human gut

Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of deaths reported worldwide each year.

14 Jan 2026

Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study

A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Sweden.

14 Jan 2026

Dietary protein reshapes how cholera bacteria colonize the gut

Researchers investigate the role of dietary components and the gut microbiota in cholera.

13 Jan 2026

One thousand days of conflict push Sudan’s health system toward collapse

Today, the conflict in Sudan reaches its 1000th day, with over 20 million people requiring health assistance and 21 million desperately needing food.

12 Jan 2026

A high-protein diet shows strong anti-cholera effects

Cholera, a severe bacterial infection that causes diarrhea and kills if untreated, can be defeated with a diet high in protein, according to a new study from UC Riverside.

8 Jan 2026

Single-dose oral cholera vaccine shows promising results in early clinical trial

Clinical trial shows promising results for PanChol, a single-dose oral vaccine aimed at the up to 4 million annual cholera cases worldwide.

7 Jan 2026

Climate shocks creating new pathways for disease across Africa

Climate shocks are reshaping ecosystems, creating new pathways for disease across Africa, writes Albert Ansah.

15 Dec 2025

Regional crises and climate shocks drive global resurgence of cholera

Cholera, caused by Vibrio cholerae, spreads through contaminated water and thrives where sanitation systems have collapsed. Once inside the body, it dehydrates victims within hours, but with prompt treatment, nearly every life can be saved.

27 Nov 2025

Nasal vaccine shows promise as a non-invasive treatment for cervical cancer

Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide.

12 Nov 2025

New typhoid conjugate vaccine shows safety and strong immune response in Africa

PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.®

12 Nov 2025

Experimental intranasal vaccine triggers broad immune response against multiple strains of H5N1

Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) reported encouraging results from an early phase clinical trial that found an experimental intranasal vaccine triggered a broad immune response against multiple strains of H5N1 "bird flu".

6 Nov 2025

WHO condemns violence amid escalating crisis in North Darfur's El Fasher

The World Health Organization (WHO) condemns the reported killing of more than 460 patients and their companions, as well as the abduction of six health workers, on 28 October from the Saudi Maternity Hospital in El Fasher.

30 Oct 2025

UC Riverside receives $2 million grant to explore how gut bacteria shape human health

One day, bottles of probiotics might do more than keep you regular -- they could help prevent disease. To get there, a $2 million grant to UC Riverside will explore how gut bacteria shape human health.

23 Sep 2025

WHO publishes global statistics highlighting cholera outbreaks and deaths in 2024

The World Health Organization (WHO) has published its global cholera statistics for 2024, showing an increase in both the number of people who fell sick and died from the disease.

13 Sep 2025

Ivermectin mass treatment shows great promise in reducing malaria transmission

Ivermectin administered to the whole population significantly reduces malaria transmission, offering new hope in the fight against the disease.

24 Jul 2025

Synthetic Biology and the Pursuit of Living Diagnostics and Therapeutics

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding the field of synthetic biology and the potential of living diagnostics.

From Pittcon 7 Jul 2025

Genetic bottlenecks limit the rise of pandemic cholera strains

A new study by the Genomics and Microbial Evolution Group at the Miguel Hernández University of Elche (UMH) together with the Department of Host-Microbe Interactions at St. Jude Children's Research Hospital in Memphis, USA, sheds light on one of the great enigmas of microbiology: why only certain strains of common bacteria become pandemic pathogens.

30 Jun 2025

Improving WASH access is key to ending cholera in vulnerable countries by 2030

The United Nations Sustainable Development Goals (UNSDG) include targets for safe drinking water, sanitation, and hygiene (WASH), which are critical in preventing cholera, a persistent health threat in low- and middle-income countries (LMICs).

24 Jun 2025

Mass treatment with the antibiotic azithromycin may lead to increased drug resistance

Efforts to reduce child mortality in Africa via mass treatment with the antibiotic azithromycin (AZM) may lead to increased drug resistance in bacteria that frequently cause pneumonia and meningitis, highlighting the need for careful monitoring, finds a new study led by UCL.

4 Jun 2025

Understanding how cholera bacteria resist phage predation

When we think of cholera, most of us picture contaminated water and tragic outbreaks in vulnerable regions. But behind the scenes, cholera bacteria are locked in a fierce, microscopic war-one that could shape the course of pandemics.

22 May 2025

Cholera

Overview

Cholera Transmission

Cholera Prevention

Cholera Epidemiology

Feature Articles

Cholera Diagnosis

Latest Cholera News and Research

Scientists reveal how cholera bacteria activate toxin genes in the human gut

Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study

Dietary protein reshapes how cholera bacteria colonize the gut

One thousand days of conflict push Sudan’s health system toward collapse

A high-protein diet shows strong anti-cholera effects

Single-dose oral cholera vaccine shows promising results in early clinical trial

Climate shocks creating new pathways for disease across Africa

Regional crises and climate shocks drive global resurgence of cholera

Nasal vaccine shows promise as a non-invasive treatment for cervical cancer

New typhoid conjugate vaccine shows safety and strong immune response in Africa

Experimental intranasal vaccine triggers broad immune response against multiple strains of H5N1

WHO condemns violence amid escalating crisis in North Darfur's El Fasher

UC Riverside receives $2 million grant to explore how gut bacteria shape human health

WHO publishes global statistics highlighting cholera outbreaks and deaths in 2024

Ivermectin mass treatment shows great promise in reducing malaria transmission

Synthetic Biology and the Pursuit of Living Diagnostics and Therapeutics

Genetic bottlenecks limit the rise of pandemic cholera strains

Improving WASH access is key to ending cholera in vulnerable countries by 2030

Mass treatment with the antibiotic azithromycin may lead to increased drug resistance

Understanding how cholera bacteria resist phage predation

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Cholera

Overview

Feature Articles

Cholera Diagnosis

Latest Cholera News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in